Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases
Bioactive compounds are comprised of small quantities of extra nutritional constituents providing both health benefits and enhanced nutritional value, based on their ability to modulate one or more metabolic processes. Plant-based diets are being thoroughly researched for their cardiovascular proper...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/127dd05075cf439d859809af2055da91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:127dd05075cf439d859809af2055da91 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:127dd05075cf439d859809af2055da912021-11-25T16:43:07ZBioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases10.3390/app1122110312076-3417https://doaj.org/article/127dd05075cf439d859809af2055da912021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/22/11031https://doaj.org/toc/2076-3417Bioactive compounds are comprised of small quantities of extra nutritional constituents providing both health benefits and enhanced nutritional value, based on their ability to modulate one or more metabolic processes. Plant-based diets are being thoroughly researched for their cardiovascular properties and effectiveness against cancer. Flavonoids, phytoestrogens, phenolic compounds, and carotenoids are some of the bioactive compounds that aim to work in prevention and treating the cardiovascular disease in a systemic manner, including hypertension, atherosclerosis, and heart failure. Their antioxidant and anti-inflammatory properties are the most important characteristics that make them favorable candidates for CVDs treatment. However, their low water solubility and stability results in low bioavailability, limited accessibility, and poor absorption. The oral delivery of bioactive compounds is constrained due to physiological barriers such as the pH, mucus layer, gastrointestinal enzymes, epithelium, etc. The present review aims to revise the main bioactive compounds with a significant role in CVDs in terms of preventive, diagnostic, and treatment measures. The advantages of nanoformulations and novel multifunctional nanomaterials development are described in order to overcome multiple obstacles, including the physiological ones, by summarizing the most recent preclinical data and clinical trials reported in the literature. Nanotechnologies will open a new window in the area of CVDs with the opportunity to achieve effective treatment, better prognosis, and less adverse effects on non-target tissues.Rakesh K. SindhuAnnima GoyalEvren Algın YaparSimona CavaluMDPI AGarticlebioactive compoundscardiovascularnanodeliverybioavailabilityTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 11031, p 11031 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
bioactive compounds cardiovascular nanodelivery bioavailability Technology T Engineering (General). Civil engineering (General) TA1-2040 Biology (General) QH301-705.5 Physics QC1-999 Chemistry QD1-999 |
spellingShingle |
bioactive compounds cardiovascular nanodelivery bioavailability Technology T Engineering (General). Civil engineering (General) TA1-2040 Biology (General) QH301-705.5 Physics QC1-999 Chemistry QD1-999 Rakesh K. Sindhu Annima Goyal Evren Algın Yapar Simona Cavalu Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases |
description |
Bioactive compounds are comprised of small quantities of extra nutritional constituents providing both health benefits and enhanced nutritional value, based on their ability to modulate one or more metabolic processes. Plant-based diets are being thoroughly researched for their cardiovascular properties and effectiveness against cancer. Flavonoids, phytoestrogens, phenolic compounds, and carotenoids are some of the bioactive compounds that aim to work in prevention and treating the cardiovascular disease in a systemic manner, including hypertension, atherosclerosis, and heart failure. Their antioxidant and anti-inflammatory properties are the most important characteristics that make them favorable candidates for CVDs treatment. However, their low water solubility and stability results in low bioavailability, limited accessibility, and poor absorption. The oral delivery of bioactive compounds is constrained due to physiological barriers such as the pH, mucus layer, gastrointestinal enzymes, epithelium, etc. The present review aims to revise the main bioactive compounds with a significant role in CVDs in terms of preventive, diagnostic, and treatment measures. The advantages of nanoformulations and novel multifunctional nanomaterials development are described in order to overcome multiple obstacles, including the physiological ones, by summarizing the most recent preclinical data and clinical trials reported in the literature. Nanotechnologies will open a new window in the area of CVDs with the opportunity to achieve effective treatment, better prognosis, and less adverse effects on non-target tissues. |
format |
article |
author |
Rakesh K. Sindhu Annima Goyal Evren Algın Yapar Simona Cavalu |
author_facet |
Rakesh K. Sindhu Annima Goyal Evren Algın Yapar Simona Cavalu |
author_sort |
Rakesh K. Sindhu |
title |
Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases |
title_short |
Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases |
title_full |
Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases |
title_fullStr |
Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases |
title_full_unstemmed |
Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases |
title_sort |
bioactive compounds and nanodelivery perspectives for treatment of cardiovascular diseases |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/127dd05075cf439d859809af2055da91 |
work_keys_str_mv |
AT rakeshksindhu bioactivecompoundsandnanodeliveryperspectivesfortreatmentofcardiovasculardiseases AT annimagoyal bioactivecompoundsandnanodeliveryperspectivesfortreatmentofcardiovasculardiseases AT evrenalgınyapar bioactivecompoundsandnanodeliveryperspectivesfortreatmentofcardiovasculardiseases AT simonacavalu bioactivecompoundsandnanodeliveryperspectivesfortreatmentofcardiovasculardiseases |
_version_ |
1718413001056321536 |